|
× |
 |
Risperidone for Severe Tardive Dyskinesia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Depression, Obesity, and Metabolic Syndrome: Prevalence and Risks of Comorbidity in a Population-Based Representative Sample of Mexican Americans PDF |
$40.00 |
|
$40.00 |
|
× |
|
Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Single-Blind, Randomized Trial Comparing Quetiapine and Haloperidol in the Treatment of Tardive Dyskinesia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Tolerability of Ziprasidone Versus Risperidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: An 8-Week, Double-Blind, Multicenter Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
e-Etiquette PDF |
$40.00 |
|
$40.00 |
|
× |
|
Gepirone Extended-Release in the Treatment of Adult Outpatients With Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Naturalistic Comparison of Clozapine, Risperidone, and Olanzapine in the Treatment of Bipolar Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Use of the ECHO Model to Improve Outcomes for Depressed Patients During the Era of COVID-19 PDF |
$40.00 |
|
$40.00 |
|
× |
|
Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients PDF |
$40.00 |
|
$40.00 |
|
|
